Daniel D. Burton, Chief Executive Officer at Health Catalyst, Inc. (HCAT), sold 245,736 shares at $32.68 ($7.9M) on 2020-08-21, disclosed to the SEC on 2020-08-24.
Open-market sale of $7.9M HCAT by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $32.40 | 50,603 | $1.6M | 20.7% |
| 2 | $32.40 | 50,603 | $1.6M | 20.7% |
| 3 | $32.08 | 69,694 | $2.2M | 28.2% |
| 4 | $32.08 | 69,694 | $2.2M | 28.2% |
| 5 | $32.68 | 2,571 | $84K | 1.1% |
| 6 | $32.68 | 2,571 |
| $84K |
| 1.1% |
| Total | $32.22 avg | 245,736 | $7.9M | 100% |
| Filing → |
| HCAT | BUY | 2022-11-14 | $4.0M | — | Filing → |
| HCAT | BUY | 2022-09-08 | $2.0M | — | Filing → |
| HCAT | BUY | 2022-08-09 | $4.1M | — | Filing → |